Physician

Alan Y Sadah, M.D.

According to 2025 Medicare claims, Alan Sadah, M.D. (NPI: 1679510275) practices urology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is METRO CHICAGO SURGICAL ONCOLOGY LLC (NPI: 1043501448; TIN: 274478152) and primary practice location at 60169-5020.

Sadah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 427 traditional Medicare patients, billed 1,968 HCPCS/CPT codes, and received $160,349 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,455 prescription claims across 351 beneficiaries totaling $596,067 in drug costs, led by Erleada (Apalutamide). DME data shows 25 claims. Open Payments data shows 37 records totaling $761. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $61,090 to $596,067. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	286	3,147	$166,115
2016	314	5,397	$184,040
2017	461	8,678	$224,841
2018	534	6,217	$201,688
2019	519	3,893	$228,465
2020	405	5,067	$219,743
2021	390	5,229	$214,207
2022	391	3,642	$163,550
2023	375	1,512	$127,404
2024	427	1,968	$160,349

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	169	620	$61,090
2016	168	610	$215,283
2017	266	876	$422,115
2018	319	1,345	$484,896
2019	355	1,476	$292,682
2020	329	1,463	$196,367
2021	340	1,448	$228,719
2022	320	1,452	$489,693
2023	332	1,427	$522,240
2024	351	1,455	$596,067

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	34	$5,385
2016	N/R	68	$13,598
2017	N/R	42	$16,493
2018	N/R	33	$18,304
2019	N/R	46	$18,607
2020	N/R	82	$27,272
2021	N/R	80	$28,464
2022	N/R	85	$32,792
2023	N/R	42	$7,920
2024	N/R	25	$5,116

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	58	58	$131
76872	Ultrasound scan of pelvic region through rectum	79	80	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	166	252	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	211	319	$66
81002	Urinalysis, manual test	84	98	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	18	540	$291,551
Xtandi	Enzalutamide	15	450	$205,034
Gemtesa	Vibegron	62	2,253	$35,854
Myrbetriq	Mirabegron	34	1,080	$16,402
Xyosted	Testosterone Enanthate	16	616	$13,310

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	25	$5,116

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$761	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alan Y. Sadah, M.D.?

Tedicare shows public-source Medicare data for Alan Y. Sadah, M.D. (NPI 1679510275), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Y. Sadah, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan Y. Sadah, M.D.?

Alan Y. Sadah, M.D. is linked to METRO CHICAGO SURGICAL ONCOLOGY LLC (billing NPI 1043501448) in the available physician profile data.

Does Alan Y. Sadah, M.D. have Open Payments data?

Alan Y. Sadah, M.D. has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.